-
1
-
-
14644396096
-
Nanomedicine: current status and future prospects
-
Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J 2005, 19:311-330.
-
(2005)
FASEB J
, vol.19
, pp. 311-330
-
-
Moghimi, S.M.1
Hunter, A.C.2
Murray, J.C.3
-
2
-
-
81855198887
-
Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective
-
Moghimi S.M., Hunter A.C., Andresen T.L. Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective. Annu Rev Pharmacol Toxicol 2012, 52:381-503.
-
(2012)
Annu Rev Pharmacol Toxicol
, vol.52
, pp. 381-503
-
-
Moghimi, S.M.1
Hunter, A.C.2
Andresen, T.L.3
-
3
-
-
84861669644
-
Doxil(r)-The first FDA-approved nano-drug: lessons learned
-
Barenholz Y. Doxil(r)-The first FDA-approved nano-drug: lessons learned. J Control Rel 2012, 160:117-133.
-
(2012)
J Control Rel
, vol.160
, pp. 117-133
-
-
Barenholz, Y.1
-
4
-
-
81855218204
-
Reshaping the future of nanopharmaceuticals: ad iudicium
-
Moghimi S.M., Peer D., Langer R. Reshaping the future of nanopharmaceuticals: ad iudicium. ACS Nano 2011, 5:8353-8358.
-
(2011)
ACS Nano
, vol.5
, pp. 8353-8358
-
-
Moghimi, S.M.1
Peer, D.2
Langer, R.3
-
5
-
-
80053605725
-
Theranostic nanomedicine
-
Lammers T., Aime S., Hennink W.E., Storm G., Kiessling F. Theranostic nanomedicine. Acc Chem Res 2011, 33:1029-1038.
-
(2011)
Acc Chem Res
, vol.33
, pp. 1029-1038
-
-
Lammers, T.1
Aime, S.2
Hennink, W.E.3
Storm, G.4
Kiessling, F.5
-
6
-
-
84870236985
-
Anticancer nanomedicine and tumor vascular permeability; where is the missing link?
-
Taurin S., Nehoff H., Greish K. Anticancer nanomedicine and tumor vascular permeability; where is the missing link?. J Control Rel 2012, 163:265-275.
-
(2012)
J Control Rel
, vol.163
, pp. 265-275
-
-
Taurin, S.1
Nehoff, H.2
Greish, K.3
-
8
-
-
84884915152
-
Facing the truth about nanotechnology in drug delivery
-
Park K. Facing the truth about nanotechnology in drug delivery. ACS Nano 2013, 7:7332-7337.
-
(2013)
ACS Nano
, vol.7
, pp. 7332-7337
-
-
Park, K.1
-
9
-
-
84886310583
-
Strategies for advancing cancer nanomedicine
-
Chauhan V.P., Jain R.K. Strategies for advancing cancer nanomedicine. Nat Mat 2013, 12:958-962.
-
(2013)
Nat Mat
, vol.12
, pp. 958-962
-
-
Chauhan, V.P.1
Jain, R.K.2
-
11
-
-
0022858683
-
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
-
Matsumura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986, 36:6387-6392.
-
(1986)
Cancer Res
, vol.36
, pp. 6387-6392
-
-
Matsumura, Y.1
Maeda, H.2
-
12
-
-
0022495733
-
Microvascular permeability of normal and neoplastic tissues
-
Gerlowski L.E., Jain R.K. Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986, 31:288-305.
-
(1986)
Microvasc Res
, vol.31
, pp. 288-305
-
-
Gerlowski, L.E.1
Jain, R.K.2
-
13
-
-
0032516078
-
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment
-
Hobbs S.K., Monsky W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998, 95:3607-3612.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 3607-3612
-
-
Hobbs, S.K.1
Monsky, W.L.2
Yuan, F.3
Roberts, W.G.4
Griffith, L.5
Torchilin, V.P.6
-
14
-
-
0035816177
-
Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function
-
Jain R.K. Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J Control Rel 2001, 73:7-25.
-
(2001)
J Control Rel
, vol.73
, pp. 7-25
-
-
Jain, R.K.1
-
15
-
-
0037036136
-
Lymphatic metastasis in the absence of functional intratumor lymphatics
-
Padera T.P., Kadambi A., di Tomaso E., Carreira C.M., Brown E.B., Boucher Y., et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 2002, 296:1883-1886.
-
(2002)
Science
, vol.296
, pp. 1883-1886
-
-
Padera, T.P.1
Kadambi, A.2
di Tomaso, E.3
Carreira, C.M.4
Brown, E.B.5
Boucher, Y.6
-
16
-
-
79551629547
-
Is human cell therapy research caught in a mousetrap?
-
Barrett A.J., Melenhorst J.J. Is human cell therapy research caught in a mousetrap?. Mol Ther 2011, 19:224-227.
-
(2011)
Mol Ther
, vol.19
, pp. 224-227
-
-
Barrett, A.J.1
Melenhorst, J.J.2
-
17
-
-
84860620155
-
Cancer stromal targeting (CAST) therapy
-
Matsumura Y. Cancer stromal targeting (CAST) therapy. Adv Drug Deliv Rev 2012, 64:710-719.
-
(2012)
Adv Drug Deliv Rev
, vol.64
, pp. 710-719
-
-
Matsumura, Y.1
-
19
-
-
0035127410
-
Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes
-
Harrington K.J., Mohammadtaghi S., Uster P.S., Glaa D., Peters A.M., Vile R.G., et al. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 2001, 7:233-253.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 233-253
-
-
Harrington, K.J.1
Mohammadtaghi, S.2
Uster, P.S.3
Glaa, D.4
Peters, A.M.5
Vile, R.G.6
-
20
-
-
84896504632
-
Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles
-
Toy R., Peiris P.M., Ghaghada K.B., Karathanasis E. Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (Lond) 2013, 9:121-133.
-
(2013)
Nanomedicine (Lond)
, vol.9
, pp. 121-133
-
-
Toy, R.1
Peiris, P.M.2
Ghaghada, K.B.3
Karathanasis, E.4
-
21
-
-
0029379535
-
Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents
-
Moghimi S.M. Mechanisms of splenic clearance of blood cells and particles: towards development of new splenotropic agents. Adv Drug Deliv Rev 1995, 17:103-115.
-
(1995)
Adv Drug Deliv Rev
, vol.17
, pp. 103-115
-
-
Moghimi, S.M.1
-
22
-
-
38549112058
-
Translation of new cancer treatments from pet dogs to humans
-
Paoloni M., Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 2008, 8:137-156.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 137-156
-
-
Paoloni, M.1
Khanna, C.2
-
23
-
-
84255196931
-
Immune microenvironments in solid tumors: new targets for therapy
-
Shiao S.L., Ganesan P., Rugo H.S., Coussens L.M. Immune microenvironments in solid tumors: new targets for therapy. Genes Dev 2011, 25:2559-2572.
-
(2011)
Genes Dev
, vol.25
, pp. 2559-2572
-
-
Shiao, S.L.1
Ganesan, P.2
Rugo, H.S.3
Coussens, L.M.4
-
24
-
-
84866784798
-
Leukocyte complexity in breast cancer predicts overall survival and functionally regulates response to chemotherapy
-
De Nardo D.G., Brennan D., Rexhapaj E., Ruffel B., Shiao S., Gallagher W.M., et al. Leukocyte complexity in breast cancer predicts overall survival and functionally regulates response to chemotherapy. Cancer Discov 2011, 1:54-67.
-
(2011)
Cancer Discov
, vol.1
, pp. 54-67
-
-
De Nardo, D.G.1
Brennan, D.2
Rexhapaj, E.3
Ruffel, B.4
Shiao, S.5
Gallagher, W.M.6
-
25
-
-
78651461701
-
HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through down- regulation of PlGF
-
Rolney C., Mazzone M., Tugues S., Laoui D., Johansson I., Coulon C., et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through down- regulation of PlGF. Cancer Cell 2011, 19:31-44.
-
(2011)
Cancer Cell
, vol.19
, pp. 31-44
-
-
Rolney, C.1
Mazzone, M.2
Tugues, S.3
Laoui, D.4
Johansson, I.5
Coulon, C.6
-
26
-
-
27144466756
-
Only a specific subset of human peripheral blood monocytes has endothelial-like functional capacity
-
Elsheikh E., Uzunel M., He Z., Holgersson J., Nowak G., Sumitran- Holgersson S. Only a specific subset of human peripheral blood monocytes has endothelial-like functional capacity. Blood 2005, 106:2347-2355.
-
(2005)
Blood
, vol.106
, pp. 2347-2355
-
-
Elsheikh, E.1
Uzunel, M.2
He, Z.3
Holgersson, J.4
Nowak, G.5
Sumitran-Holgersson, S.6
-
27
-
-
34249979533
-
Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer
-
Venneri M.A., Palma M.D., Ponzoni M., Pucci F., Scielzo C., Zonari E., et al. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 2007, 109:5276-5285.
-
(2007)
Blood
, vol.109
, pp. 5276-5285
-
-
Venneri, M.A.1
Palma, M.D.2
Ponzoni, M.3
Pucci, F.4
Scielzo, C.5
Zonari, E.6
-
28
-
-
4644345036
-
Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of VEGF-A
-
Conejo-Garcia J.R., Benencia F., Courreges M.C., Kang E., Mohamed-Hadley A., Buckanovich R.J., et al. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of VEGF-A. Nat Med 2004, 10:950-958.
-
(2004)
Nat Med
, vol.10
, pp. 950-958
-
-
Conejo-Garcia, J.R.1
Benencia, F.2
Courreges, M.C.3
Kang, E.4
Mohamed-Hadley, A.5
Buckanovich, R.J.6
-
29
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004, 10:942-949.
-
(2004)
Nat Med
, vol.10
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
-
30
-
-
54549109936
-
Modulation of the antitumor immune responses by complement
-
Markiewski M.M., DeAngelis R.A., Benencia F., Ricklin-Lichtsteiner S.K., Koutoulaki A., Gerard C., et al. Modulation of the antitumor immune responses by complement. Nat Immunol 2008, 9:1225-1235.
-
(2008)
Nat Immunol
, vol.9
, pp. 1225-1235
-
-
Markiewski, M.M.1
DeAngelis, R.A.2
Benencia, F.3
Ricklin-Lichtsteiner, S.K.4
Koutoulaki, A.5
Gerard, C.6
-
31
-
-
80052154470
-
Material properties in complement activation
-
Moghimi S.M., Andersen A.J., Ahmadvand D., Wibroe P.P., Andresen T.L., Hunter A.C. Material properties in complement activation. Adv Drug Deliv Rev 2011, 63:1000-1007.
-
(2011)
Adv Drug Deliv Rev
, vol.63
, pp. 1000-1007
-
-
Moghimi, S.M.1
Andersen, A.J.2
Ahmadvand, D.3
Wibroe, P.P.4
Andresen, T.L.5
Hunter, A.C.6
-
32
-
-
64149086047
-
Complement-mediated tumour growth: implications for cancer nanotechnology and nanomedicines
-
Moghimi S.M., Andresen T.L. Complement-mediated tumour growth: implications for cancer nanotechnology and nanomedicines. Mol Immunol 2009, 36:1571-1572.
-
(2009)
Mol Immunol
, vol.36
, pp. 1571-1572
-
-
Moghimi, S.M.1
Andresen, T.L.2
-
33
-
-
84906783842
-
Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth
-
[in press]
-
Moghimi S.M. Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth. J Control Rel 2014, [in press]. 10.1016/j.jconrel.2014.03.051.
-
(2014)
J Control Rel
-
-
Moghimi, S.M.1
-
34
-
-
84889840938
-
Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase
-
Gong L., Cumpian A.M., Catano M.S., Ochoa C.E., la Garza MM De, Lapid D.J., et al. Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase. Mol Cancer 2013, 12:154. [http://www.molecular-cancer.com/content/12/1/154].
-
(2013)
Mol Cancer
, vol.12
, pp. 154
-
-
Gong, L.1
Cumpian, A.M.2
Catano, M.S.3
Ochoa, C.E.4
la Garza MM, D.5
Lapid, D.J.6
-
35
-
-
0031135489
-
Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils
-
Wirthmueller U., Dewald B., Thelen M., Schafer M.K., Stover C., Whaley K., et al. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J Immunol 1997, 158:4444-4451.
-
(1997)
J Immunol
, vol.158
, pp. 4444-4451
-
-
Wirthmueller, U.1
Dewald, B.2
Thelen, M.3
Schafer, M.K.4
Stover, C.5
Whaley, K.6
-
36
-
-
33748445698
-
Malignancy and hemostasis
-
LippinCott Williams & Wilkins, Philadelphia, R.W. Coleman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldharber (Eds.)
-
Dvorak H.F., Rickles F.R. Malignancy and hemostasis. Hemostasis and Thrombosis: Basic Principles and Clinical Practice 2006, 851-873. LippinCott Williams & Wilkins, Philadelphia. 5th ed. R.W. Coleman, V.J. Marder, A.W. Clowes, J.N. George, S.Z. Goldharber (Eds.).
-
(2006)
Hemostasis and Thrombosis: Basic Principles and Clinical Practice
, pp. 851-873
-
-
Dvorak, H.F.1
Rickles, F.R.2
-
37
-
-
33947602404
-
Complement and coagulation: strangers or partners in crime?
-
Markiewski M.M., Nilsson B., Nilsson-Ekdahl K., Mollnes T.E., Lambris J.D. Complement and coagulation: strangers or partners in crime?. Trend Immunol 2007, 28:183-192.
-
(2007)
Trend Immunol
, vol.28
, pp. 183-192
-
-
Markiewski, M.M.1
Nilsson, B.2
Nilsson-Ekdahl, K.3
Mollnes, T.E.4
Lambris, J.D.5
-
38
-
-
33846545130
-
Biomimetic amplification of nanoparticle homing to tumors
-
Simberg D., Duza T., Park J.H., Essler M., Pilch J., Zhang L.L., et al. Biomimetic amplification of nanoparticle homing to tumors. Proc Natl Acad Sci USA 2007, 104:932-936.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 932-936
-
-
Simberg, D.1
Duza, T.2
Park, J.H.3
Essler, M.4
Pilch, J.5
Zhang, L.L.6
-
39
-
-
84866149234
-
Opposing roles of complement component C5a in tumor progression and the tumor microenvironment
-
Gunn L., Ding C., Liu M., Ma Y., Qi C., Cai Y., et al. Opposing roles of complement component C5a in tumor progression and the tumor microenvironment. J Immunol 2012, 189:2985-2993.
-
(2012)
J Immunol
, vol.189
, pp. 2985-2993
-
-
Gunn, L.1
Ding, C.2
Liu, M.3
Ma, Y.4
Qi, C.5
Cai, Y.6
-
40
-
-
84855381793
-
Immunological variations between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice
-
Sellers R.S., Clifford C.B., Treuting P.M., Brayton C. Immunological variations between inbred laboratory mouse strains: points to consider in phenotyping genetically immunomodified mice. Vet Pathol 2012, 39:32-33.
-
(2012)
Vet Pathol
, vol.39
, pp. 32-33
-
-
Sellers, R.S.1
Clifford, C.B.2
Treuting, P.M.3
Brayton, C.4
-
41
-
-
1542320497
-
Cancer cells compress intratumor vessels
-
Padera T.P., Stoll B.R., Tooredman J.B., Capen D., di Tomaso E., Jain R.K. Cancer cells compress intratumor vessels. Nature 2003, 327:695.
-
(2003)
Nature
, vol.327
, pp. 695
-
-
Padera, T.P.1
Stoll, B.R.2
Tooredman, J.B.3
Capen, D.4
di Tomaso, E.5
Jain, R.K.6
-
42
-
-
2342481765
-
Complement activation by apoptotic cells occurs predominantly via IgM and is limited to late apoptotic (secondary necrotic) cells
-
Zwart B., Ciutana C., Rensink I., Manoe R., Hack C.E., Aarden L.A. Complement activation by apoptotic cells occurs predominantly via IgM and is limited to late apoptotic (secondary necrotic) cells. Autoimmunity 2003, 37:95-102.
-
(2003)
Autoimmunity
, vol.37
, pp. 95-102
-
-
Zwart, B.1
Ciutana, C.2
Rensink, I.3
Manoe, R.4
Hack, C.E.5
Aarden, L.A.6
-
43
-
-
48249124246
-
The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis
-
Kemper C., Mitchell L.M., Zhang L., Hourcade D.E. The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. Proc Natl Acad Sci USA 2008, 105:9023-9028.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 9023-9028
-
-
Kemper, C.1
Mitchell, L.M.2
Zhang, L.3
Hourcade, D.E.4
-
44
-
-
84873268296
-
The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
-
Maeda H., Nakamura H., Fang J. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. Adv Drug Deliv Rev 2013, 65:71-79.
-
(2013)
Adv Drug Deliv Rev
, vol.65
, pp. 71-79
-
-
Maeda, H.1
Nakamura, H.2
Fang, J.3
-
45
-
-
79952594233
-
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
-
Diop-Frimpong B., Chauhan V.P., Krane S., Boucher Y., Jain R.K. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci USA 2011, 108:2909-2913.
-
(2011)
Proc Natl Acad Sci USA
, vol.108
, pp. 2909-2913
-
-
Diop-Frimpong, B.1
Chauhan, V.P.2
Krane, S.3
Boucher, Y.4
Jain, R.K.5
-
46
-
-
84887478772
-
Combining two strategies to improve perfusion and drug delivery in solid tumors
-
Stylianopoulos T., Jain R.K. Combining two strategies to improve perfusion and drug delivery in solid tumors. Proc Natl Acad Sci USA 2013, 110:18632-18637.
-
(2013)
Proc Natl Acad Sci USA
, vol.110
, pp. 18632-18637
-
-
Stylianopoulos, T.1
Jain, R.K.2
-
47
-
-
84866735036
-
Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer
-
Kato K., Chin K., Yoshikawa T., Yamaguchi K., Tsuji Y., Esaki T., et al. Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer. Invest New Drug 2012, 30:1621-1627.
-
(2012)
Invest New Drug
, vol.30
, pp. 1621-1627
-
-
Kato, K.1
Chin, K.2
Yoshikawa, T.3
Yamaguchi, K.4
Tsuji, Y.5
Esaki, T.6
-
48
-
-
84863393080
-
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
-
Gerlinger M., Rowan A.J., Horswell S., Larkin J., Endesfelder D., Gronroos E., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012, 366:883-892.
-
(2012)
N Engl J Med
, vol.366
, pp. 883-892
-
-
Gerlinger, M.1
Rowan, A.J.2
Horswell, S.3
Larkin, J.4
Endesfelder, D.5
Gronroos, E.6
-
49
-
-
80053997259
-
A human memory T cell subset with stem cell-like properties
-
Gattinoni L., Lugli E., Ji Y., Pos Z., Paulos C.M., Quigley M.F., et al. A human memory T cell subset with stem cell-like properties. Nat Med 2011, 17:1290-1297.
-
(2011)
Nat Med
, vol.17
, pp. 1290-1297
-
-
Gattinoni, L.1
Lugli, E.2
Ji, Y.3
Pos, Z.4
Paulos, C.M.5
Quigley, M.F.6
-
50
-
-
79251468712
-
Mouse models of advanced spontaneous metastasis for experimental therapeutics
-
Francia G., Cruz-Munoz W., Man S., Xu P., Kerbel R.S. Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nat Rev Cancer 2011, 11:135-141.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 135-141
-
-
Francia, G.1
Cruz-Munoz, W.2
Man, S.3
Xu, P.4
Kerbel, R.S.5
-
51
-
-
80052472086
-
Primary human tumor xenografted models ('tumorgrafts') for good management of patients with cancer
-
Decaudin D. Primary human tumor xenografted models ('tumorgrafts') for good management of patients with cancer. Anticancer Drugs 2011, 22:827-831.
-
(2011)
Anticancer Drugs
, vol.22
, pp. 827-831
-
-
Decaudin, D.1
-
52
-
-
84860540820
-
Human tumor xenografts: the good, the bad and the ugly
-
Morgan R.A. Human tumor xenografts: the good, the bad and the ugly. Mol Ther 2012, 20:882-883.
-
(2012)
Mol Ther
, vol.20
, pp. 882-883
-
-
Morgan, R.A.1
|